RFG Advisory LLC purchased a new stake in Incyte Co. (NASDAQ:INCY – Get Rating) in the fourth quarter, HoldingsChannel reports. The fund purchased 3,050 shares of the biopharmaceutical company’s stock, valued at approximately $224,000. Several other large investors have also made changes to their positions in INCY. IndexIQ Advisors LLC raised its position in Incyte […]
National Asset Management Inc. boosted its holdings in Incyte Co. (NASDAQ:INCY – Get Rating) by 5.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,255 shares of the biopharmaceutical company’s stock after acquiring an additional 164 shares during the quarter. National Asset Management […]
Incyte (NASDAQ:INCY – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday, Zacks.com reports. The firm currently has a $85.00 price objective on the biopharmaceutical company’s stock. Zacks Investment Research‘s target price would indicate a potential upside of 3.82% […]
Obermeyer Wood Investment Counsel Lllp lowered its stake in shares of Incyte Co. (NASDAQ:INCY – Get Rating) by 68.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,949 shares of the biopharmaceutical company’s stock after selling 6,336 shares during the […]
Van ECK Associates Corp lessened its holdings in shares of Incyte Co. (NASDAQ:INCY – Get Rating) by 10.4% during the fourth quarter, HoldingsChannel reports. The firm owned 151,201 shares of the biopharmaceutical company’s stock after selling 17,464 shares during the quarter. Van ECK Associates Corp’s holdings in Incyte were worth $11,098,000 at the end of […]